Observations placeholder
Treprostinil, Remodulin, Tyvaso
Identifier
015765
Type of Spiritual Experience
Number of hallucinations: 27
Background
A description of the experience
Treprostinil (marketed under the trade names Remodulin for infusion and Tyvaso for inhalation) is a vasodilator that is used for the treatment of pulmonary arterial hypertension. Treprostinil is a synthetic analog of prostacyclin (PGI2).
On Jan, 02, 2017 16,282 people reported to have side effects when taking Tyvaso.
Among them, 17 people (0.1%) have Hallucination
On Jan, 16, 2017 18,618 people reported to have side effects when taking Remodulin.
Among them, 10 people (0.05%) have Hallucination
On Dec, 26, 2016 16,282 people reported to have side effects when taking Tyvaso.
Among them, 1,433 people (8.8%) have Death
Time on Tyvaso when people have Death :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
| Death | 8.70% | 47.83% | 30.43% | 13.04% | 0.00% | 0.00% | 0.00% |